
Alan M. Garber, MD, PhD
Provost, Harvard University; Mallinckrodt Professor of Health Care Policy, Professor of Economics, Harvard Kennedy School and the Faculty of Arts and Sciences
Harvard Medical SchoolDepartment of Health Care Policy180 Longwood AvenueBoston, MA 02115-5899
Cost-effectiveness of androgen suppression strategies in advanced prostate cancer.
Authors: Bayoumi AM, Brown AD, Garber AM
Journal of the National Cancer Institute
View full abstract on Pubmed
Journal of the National Cancer Institute
View full abstract on Pubmed
Using cost-effectiveness analysis to target cholesterol reduction (editorial).
Cholesterol screening in children and adolescents (comment).
A cost-effectiveness analysis of prescribing strategies in managing gastroesophageal reflux disease.
Authors: Gerson LB, Robbins AS, Garber AM, et al.
American Journal of Gastroenterology
View full abstract on Pubmed
American Journal of Gastroenterology
View full abstract on Pubmed
Realistic rigor in cost-effectiveness methods
Low molecular weight heparins compared with unfractionated heparin for the treatment of acute deep vein thrombosis: A cost-effectiveness analysis
Authors: Gould MK, Dembitzer AD, Sanders GD, et al.
Annals of Internal Medicine
View full abstract on Pubmed
Annals of Internal Medicine
View full abstract on Pubmed
Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease
Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing
Authors: Brown AD and Garber AM
Journal of the American Medical Association
View full abstract on Pubmed
Journal of the American Medical Association
View full abstract on Pubmed
Cost-effectiveness and cost benefit analysis of using methotrexate vs. Goeckerman therapy for psoriasis
Cost-effectiveness of coronary heart disease prevention strategies in adults